Item Details

Print View
Start over
Add Star

Dangerous Medicine: The Risk to American Consumers From Prescription Drug Diversion and Counterfeiting : Report by the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, U.S. House of Representatives

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations
Format
Book; Government Document; Online; EBook
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., Congressional Sales Office, 1986.
Language
English
SuDoc Number
Y 4.En 2/3:99-Z
Description
v, 31 p. ; 24 cm.
Mode of access: Internet.
Notes
  • 1019-A, 1019-B (microfiche)
  • S/N 052-070-06106-5
  • "April 1986."
  • Distributed to some depository libraries in microfiche.
  • At head of title: 99th Congress, 2d session. Committee print, 99-Z.
  • Includes bibliographical references.
Copyright & Permissions
Copyright Not EvaluatedCopyright Not Evaluated
Technical Details
  • Staff View

    LEADER 02174nam a2200517 a 4500
    001 003501004
    003 MiAaHDL
    005 20130211000000.0
    006 m d
    007 cr bn ---auaua
    008 000911s1986 dcu b f000 0 eng c
    010
      
      
    a| 86602099
    035
      
      
    a| (MiU)003501004
    035
      
      
    a| sdr-miu003501004
    035
      
      
    a| sdr-ucr.b19378130
    035
      
      
    a| (OCoLC)13545324
    037
      
      
    a| 052-070-06106-5 b| GPO
    040
      
      
    a| DGPO/DLC c| DLC d| GPO d| EYM
    043
      
      
    a| n-us---
    050
    0
    0
    a| HD9665.9.U6 b| U55 1986
    074
      
      
    a| 1019-A, 1019-B (microfiche)
    082
    0
    0
    a| 363.1/942/0973 2| 19
    086
    0
      
    a| Y 4.En 2/3:99-Z
    110
    1
      
    a| United States. b| Congress. b| House. b| Committee on Energy and Commerce. b| Subcommittee on Oversight and Investigations.
    245
    1
    0
    a| Dangerous medicine : b| the risk to American consumers from prescription drug diversion and counterfeiting : report by the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, U.S. House of Representatives.
    260
      
      
    a| Washington : b| U.S. G.P.O. : b| For sale by the Supt. of Docs., U.S. G.P.O., Congressional Sales Office, c| 1986.
    300
      
      
    a| v, 31 p. ; c| 24 cm.
    500
      
      
    a| 1019-A, 1019-B (microfiche)
    500
      
      
    a| S/N 052-070-06106-5
    500
      
      
    a| "April 1986."
    500
      
      
    a| Distributed to some depository libraries in microfiche.
    500
      
      
    a| At head of title: 99th Congress, 2d session. Committee print, 99-Z.
    504
      
      
    a| Includes bibliographical references.
    538
      
      
    a| Mode of access: Internet.
    650
      
    2
    a| Drug Contamination.
    650
      
    0
    a| Counterfeits and counterfeiting z| United States.
    650
      
    0
    a| Consumer protection z| United States.
    650
      
    0
    a| Drug adulteration z| United States.
    974
      
      
    b| MIU c| MIU d| 20161212 s| google u| mdp.39015043251415 y| 1986 r| pd q| bib
    974
      
      
    b| UC c| UCR d| 20180323 s| google u| uc1.31210016342410 y| 1986 r| pd q| bib
▾See more
▴See less
Always show full record

Access online

Google Preview

Google Books Preview

HathiTrust

Copy 1 Copy 2